*CART sound therapy* for tinnitus relief in Nucleus® cochlear implant users with tinnitus

Completed

• Conditions: ringing of the ear; Tinnitus; 10019243

• Registration Number: NL-OMON46972
• Lead Sponsor: Cochlear AG, European Headquarters

Brief Summary

Trial ended prematurely

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-01-24
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

Self-reported tinnitus during standard cochlear implant use.

Exclusion Criteria

History of psychiatric disorders or depression (on investigator*s opinion).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters are the change in VAS-scores (Visual Analog Scale) on<br /><br>tinnitus loudness and annoyance and the change in the score on the Tinnitus<br /><br>Functional Index (TFI) between baseline and intervention.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary parameters are the ratings on the acceptability of CART sounds,<br /><br>(Serious) Adverse Event reporting and speech perception tests with CART on and<br /><br>off.</p><br>